Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing

Amélie Hampel; Tamar Kinaciyan

doi:10.1111/cod.14505

Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing

Contact Dermatitis. 2024 May;90(5):525-527. doi: 10.1111/cod.14505. Epub 2024 Jan 23.

Authors

Amélie Hampel¹, Tamar Kinaciyan¹

Affiliation

¹ Department of Dermatology, Medical University of Vienna, Vienna, Austria.

PMID: 38263696
DOI: 10.1111/cod.14505

No abstract available

Keywords: baboon syndrome; chemotherapy with taxanes; cutaneous adverse drug reaction; docetaxel; paclitaxel; systemic/hematogenic contact dermatitis.

Publication types

Case Reports

MeSH terms

Dermatitis, Allergic Contact*
Docetaxel / adverse effects
Drug Eruptions* / diagnosis
Drug Eruptions* / etiology
Exanthema* / chemically induced
Exanthema* / diagnosis
Humans
Intertrigo* / chemically induced

Substances

Docetaxel